Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

Phase 2

Completed

• Conditions: Cocaine-Related Disorders; Substance-Related Disorders

• Registration Number: NCT00000274
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of flupenthixol and haloperidol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.

Detailed Description

Not available

Study Timeline

• Study Start: 1997-03
• Study Completion: 1999-05
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2016-11
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Drug use
Side effects
Psychiatric symptoms
Cocaine craving

Trial Locations

Locations (1)

New York State Psychiatric Institute; 🇺🇸 New York, New York, United States